Pancreatic Cancer Research

ResearcherColumbia UniversityActive in the last 2 years

Alexander S. Thomas

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4821-9004; OpenAlex author ID A5080591292. Sources: OpenAlex.

Their work

Papers
9 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2021: 1 paper · 2022: 3 papers · 2023: 3 papers · 2024: 2 papers

Papers 9

  1. Trends in the Care of Locally Advanced Pancreatic Cancer in the Modern Era of Chemotherapy. Co-author DOI 10.1002/jso.27851↗
  2. Inadequacy of the eighth edition of the American Joint Committee on Cancer pancreatic cancer staging system for invasive carcinoma associated with premalignant… Co-author DOI 10.1016/j.hpb.2023.11.015↗
  3. The role of local treatment including pancreatectomy for pancreatic ductal adenocarcinoma patients with isolated synchronous liver metastasis: Propensity score… Co-author DOI 10.1002/jhbp.1313↗
  4. Reconsidering the absence of extrapancreatic extension in T staging for pancreatic adenocarcinoma in the AJCC (8th ed) Staging Manual using the National Cancer… First author DOI 10.1007/s11605-023-05850-2↗
  5. Transfusion of salvaged red blood cells during pancreatic ductal adenocarcinoma operations. Co-author DOI 10.1093/bjs/znac393↗
  6. Long-term follow-up experience with adjuvant therapy after irreversible electroporation of locally advanced pancreatic cancer. Co-author DOI 10.1002/jso.27085↗
  7. Socioeconomic Predictors of Access to Care for Patients with Operatively Managed Pancreatic Cancer in New York State. Co-author DOI 10.1007/s11605-022-05320-1↗
  8. Can Surgical Resection of Metastatic Lesions Be Beneficial to Pancreatic Ductal Adenocarcinoma Patients with Isolated Lung Metastasis? Co-author DOI 10.3390/cancers14092067↗
  9. Irreversible electroporation of locally advanced pancreatic cancer. First author DOI 10.1053/j.seminoncol.2021.02.004↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michael D. Kluger · 9 shared papers, 2021–2024 · strength 1.66
  2. Wooil Kwon · 9 shared papers, 2021–2024 · strength 1.66
  3. Mirang Lee · 4 shared papers, 2022–2024 · strength 0.73
  4. Won‐Gun Yun · 4 shared papers, 2022–2024 · strength 0.73
  5. Jin‐Young Jang · 4 shared papers, 2022–2024 · strength 0.73
  6. Beth Schrope · 4 shared papers, 2022–2024 · strength 0.71
  7. John A. Chabot · 4 shared papers, 2022–2024 · strength 0.71
  8. Hye‐Sol Jung · 3 shared papers, 2023–2024 · strength 0.58
  9. Kazuki N. Sugahara · 3 shared papers, 2022–2024 · strength 0.55
  10. Gulam Abbas Manji · 2 shared papers, 2022–2024 · strength 0.36
  11. Jeanine M. Genkinger · 1 shared paper, 2024 · strength 0.21
  12. Seungyeoun Lee · 1 shared paper, 2023 · strength 0.18
  13. Neha Goel · 1 shared paper, 2023 · strength 0.17
  14. Andrew D. Rhim · 1 shared paper, 2023 · strength 0.17
  15. Kenneth P. Olive · 1 shared paper, 2023 · strength 0.17
  16. Susan Elaine Bates · 1 shared paper, 2022 · strength 0.15
  17. Hongbeom Kim · 1 shared paper, 2022 · strength 0.15
  18. David Paul Horowitz · 1 shared paper, 2022 · strength 0.15
  19. Hyeong Seok Kim · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.